Roche Group recently declared cooperation with Ascletis in joint developing Danoprevir that is used for curing Hepatitis C, marking beginning of cooperative research and development, production and sale of new drugs in China with local peers by the Swiss drug maker.
Such innovative cooperation will be continued for drugs with high demands from patients, pointed out Roche Asia Pacific President Luke Miels.
The cooperation will be a new business form launched by Roche in China and extended to other fields and local pharmaceutical companies step by step.
Source:
http://www.sinocast.com/readbeatarticle.do?id=93261
